Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterizing the Long-Term Cardiopulmonary Effects of COVID-19 With Hyperpolarized Xenon and Cardiac MRI

NCT04828135 is registered in ClinicalTrials.gov with Bastiaan Driehuys as lead sponsor.

NCT NCT04828135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04828135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterizing the Long-Term Cardiopulmonary Effects of COVID-19 With Hyperpolarized Xenon and Cardiac MRI
Lead sponsor
Bastiaan Driehuys
Phase
Phase 2
Overall status
Completed
Start date
May 26, 2021
Completion date
April 20, 2023
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19